T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
The Mosaic Company
MOS
$6.92B
| $19.1M | ﹤0.01% |
537,309
+59,930
| +13% | +$2.3M |
|
927
AtriCure
ATRC
$2.21B
| $19M | ﹤0.01% |
434,483
-1,170
| -0.3% | -$57.1K |
|
928
Expedia Group
EXPE
$39.4B
| $18.7M | ﹤0.01% |
181,750
-10,066
| -5% | -$1.11M |
|
929
Immatics
IMTX
$1.31B
| $18.7M | ﹤0.01% |
1,614,535
+893,328
| +124% | +$10.7M |
|
930
Nurix Therapeutics
NRIX
$2.82B
| $18.7M | ﹤0.01% |
2,377,978
-1,895
| -0.1% | -$17.3K |
|
931
Ormat Technologies
ORA
$6.98B
| $18.7M | ﹤0.01% |
266,730
+2,083
| +0.8% | +$162K |
|
932
Graco
GGG
$13.3B
| $18.6M | ﹤0.01% |
255,526
-46,924
| -16% | -$3.71M |
|
933
Monte Rosa Therapeutics
GLUE
$1.35B
| $18.5M | ﹤0.01% |
3,870,547
-25,951
| -0.7% | -$167K |
|
934
Herc Holdings
HRI
$5.64B
| $18.5M | ﹤0.01% |
155,521
-8,176
| -5% | -$1.07M |
|
935
Palantir
PLTR
$430B
| $18.5M | ﹤0.01% |
1,153,861
+29,319
| +3% | +$467K |
|
936
Carnival Corporation Ltd
CCL
$38.9B
| $18.4M | ﹤0.01% |
1,340,467
+5,024
| +0.4% | +$83.3K |
|
|
BCPC
937
Balchem Corp
BCPC
$5.65B
| $18.3M | ﹤0.01% |
147,437
-29,411
| -17% | -$3.91M |
|
938
LKQ Corp
LKQ
$6.38B
| $18.2M | ﹤0.01% |
367,688
+1,788
| +0.5% | +$95.7K |
|
939
FormFactor
FORM
$10.3B
| $18.1M | ﹤0.01% |
518,239
-149,419
| -22% | -$5.02M |
|
940
iShares Core S&P 500 ETF
IVV
$910B
| $18.1M | ﹤0.01% |
42,106
-493
| -1% | -$221K |
|
941
A10 Networks
ATEN
$1.96B
| $18.1M | ﹤0.01% |
1,202,238
+18,627
| +2% | +$276K |
|
942
Snap-on
SNA
$20.9B
| $17.9M | ﹤0.01% |
70,317
-1,275
| -2% | -$345K |
|
943
Revvity
RVTY
$13.1B
| $17.9M | ﹤0.01% |
161,833
-3,812
| -2% | -$448K |
|
944
WEX
WEX
$6.78B
| $17.9M | ﹤0.01% |
95,173
-6,025
| -6% | -$1.16M |
|
945
Lamb Weston
LW
$7.39B
| $17.7M | ﹤0.01% |
191,006
+578
| +0.3% | +$58.6K |
|
946
Virtus Investment Partners
VRTS
$1.14B
| $17.5M | ﹤0.01% |
86,457
-237
| -0.3% | -$48.2K |
|
947
Masco
MAS
$14.7B
| $17.4M | ﹤0.01% |
325,726
-2,599
| -0.8% | -$150K |
|
|
SFBS
948
ServisFirst Bancshares
SFBS
$5B
| $17.4M | ﹤0.01% |
333,191
+95,817
| +40% | +$5.07M |
|
949
Evolent Health
EVH
$527M
| $17.4M | ﹤0.01% |
637,878
-212,383
| -25% | -$5.9M |
|
950
Trex
TREX
$5.1B
| $17.4M | ﹤0.01% |
281,789
-304
| -0.1% | -$20.9K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.